Good Clinical Practice Workshops

Good Clinical Practice Workshops

Good Clinical Practice (GCP) Workshops are scheduled quarterly and are supplemental education to the Spectrum Clinical Research Operations Program.

 

 

 

ETHICS and GCP

Speaker: Holly Tabor, PhD.
Date:
 October 31, 2024 from 9:00am-10:30am
Location:
 Zoom meeting

Registration: Flyer coming soon. Register HERE!

 

Past GCP Workshops
June 20, 2024: Applying the Principles of Good Clinical Practice (GCP), with Kiera Davis, MSCR, RN.
February 3, 2023: FDA inspection and Audit Common Findings, with Kris Anderberg, RN, BSN.

June 5, 2023: E-Documents and E-Data in Clinical Research, with Leonard Basobas, MS.

September 15, 2023: e-protocol submissions for new studies – A practical guide to submitting applications and obtaining IRB approval, with Janet Cunningham, PhD.

October 10, 2023: Informed Consent: Working together to review, discuss and learn about Complex Cases,  with Nancy Sweeters, PNP, RN, and her team.

February 11, 2022: Quality Incidents and CAPAs, with Kristin Anderberg, RN, BSN.
August 31, 2022: Human Subjects Research (HSR) vs. Non-HSR in Clinical Trials, with Allison Greger & Dianne Ferris.
Novmber 4 , 2022: The Importance of Trial Master File (TMF) and Investigator Site File (ISF), with Kristin Anderberg, RN, BSN and Doran Triggs, BS.
December 2 , 2022: The Responsibilities of the Principal Investigator and Clinical Research Coordinator, with Kiera Davis, MSCR, RN, & Leonard Basobas, MS.

September 15, 2021: Protocol Noncompliance: Protocol Deviations, with Kiera Davis, RN, BSN.

December 2, 2021: History of Human Subjects Research Protection, with Kiera Davis, RN, BSN.

September 6, 2019: Inspection Findings after Implementation of ICH E6 R2, and CRO Oversight,” with Andrew Lawton.

August 7, 2019: Submitting Realistic Study Budgets, with Patty Kasper, MS.

March 7, 2019: Preparing for an FDA Audit, with Patty Kasper, MS.

November 9, 2018: Successful Clinical Trial Monitoring, with Savita O. Sinha, M.Sc, SOS Clinical Consulting, Instructor, UCSC Extension, has worked as a clinical research consultant for the past 20 years, managing multi-center, global phase II, phase III and post-marking studies.  She will present the essential elements of monitoring a clinical trial and the interaction between a sponsor and one or more sites during a clinical investigation. The expectations of the FDA, the sponsor and the site are covered. Participants are exposed to the process of site selection, budgeting, completion of regulatory documents, adverse event reporting, and tasks to be performed before, during and after a monitoring visit. Risk based monitoring; regulatory obligations; compliance audits; fraud and misconduct; and the importance of accurate data entry and product accountability for compliance are also covered.

August 10, 2018: The Drug Development Process: An Overview, with Edward Rozhon, PhD, Instructor and Chair of Biotechnology, Bioinformatics and Clinical Trials Design Programs at the UCSC Silicon Valley extension program, will provide an overview of the drug discovery and development process, outlining methodologies, selection of investigational drugs for clinical studies, phases of clinical trials and FDA review of a New Drug Application or Biologics License Application.

May 9, 2018: In Depth Review of ICH Guidelines for Clinical Research Coordinators, with Patty Kasper, MS.